Preclinical research comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-12-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Also called GW501516 and endurobol. |
| Chemical formula | C21H18F3NO3S2 | Molecular weight about 453.5 g/mol. |
| Appearance | White to off-white solid | Form depends on synthesis and purity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, protected from light | Common for research chemicals. |
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
Biosecurity and Nanoscience Laboratory. Researchers apply advances in nanoscience to develop novel technologies for the detection, identification, and characterization of harmful biological pathogens (viruses, spores, and bacteria) and chemical toxins. Center for Accelerator Mass Spectrometry: LLNL's Center for Accelerator Mass Spectrometry (CAMS) develops and applies a wide range of isotopic and ion-beam analytical tools used in basic research and technology development, addressing a spectrum of scientific needs important to the Laboratory, the university community, and the nation. CAMS is the world's most versatile and productive accelerator mass spectrometry facility, performing more than 25,000 AMS measurement operations per year. High Explosives Applications Facility and Energetic Materials Center: At HEAF, teams of scientists, engineers, and technicians address nearly all aspects of high explosives: research, development and testing, material characterization, and performance and safety tests. HEAF activities support the Laboratory's Energetic Materials Center, a national resource for research and development of explosives, pyrotechnics, and propellants. National Atmospheric Release Advisory Center: NARAC is a national support and resource center for planning, real-time assessment, emergency response, and detailed studies of incidents involving a wide variety of hazards, including nuclear, radiological, chemical, biological, and natural atmospheric emissions.
The diagram shows a simplified decay scheme of 60Co and 60mCo. The main β-decay transitions are shown. The probability for population of the middle energy level of 2.1 MeV by β-decay is only 0.0022%, with a β-energy of 0.67 MeV. Transitions between the three levels generate six different gamma-ray frequencies. In the diagram the two important ones are marked. Internal conversion is not significant. The half-value and 1/10th value layer thickness for shielding against this isotope's radiations has been determined for different materials:
During the crisis, China primarily tapped into its corporate stockpiles, outside its official SPR of 1.23 billion barrels, to supply domestic needs. There could also be other previously unreported reserves in China. These corporate reserves can be used at one million barrels per day for a year. China's growing renewable energy sector and electric vehicle industry have also reduced the demand for petroleum products. Although China restricted overall exports of refined oil products during the war, it still supplied limited volumes to selected partner countries, either due to friendly relations or to secure diplomatic leverage. The conflict has also provided China with an opportunity to expand its renewable energy technologies in Asia.
== Terminology == ICD-10 coding reflects both impaired-peristalsis senses and mechanical-obstruction senses of the term as modified by various adjectives. Some authors have argued for trying to reserve the term for the impaired-peristalsis senses, under which prescription certain older terms such as "gallstone ileus" and "meconium ileus", although now technically misnomers, are still accepted as correct owing to their long-established usage.
NIP7: Knockdown reduced mTORC2 activity that is indicated by decreased phosphorylation of mTORC2 substrates. RICTOR: Overexpression leads to metastasis and knockdown inhibits growth factor-induced PKC-phosphorylation. Constitutive deletion of Rictor in mice leads to embryonic lethality, while tissue specific deletion leads to a variety of phenotypes; a common phenotype of Rictor deletion in liver, white adipose tissue, and pancreatic beta cells is systemic glucose intolerance and insulin resistance in one or more tissues. Decreased Rictor expression in mice decreases male, but not female, lifespan. mTOR: Inhibition of mTORC1 and mTORC2 by PP242 [2-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-1H-indol-5-ol] leads to autophagy or apoptosis; inhibition of mTORC2 alone by PP242 prevents phosphorylation of Ser-473 site on AKT and arrests the cells in G1 phase of the cell cycle. Genetic reduction of mTOR expression in mice significantly increases lifespan. PDK1: Knockout is lethal; hypomorphic allele results in smaller organ volume and organism size but normal AKT activation. AKT: Knockout mice experience spontaneous apoptosis (AKT1), severe diabetes (AKT2), small brains (AKT3), and growth deficiency (AKT1/AKT2). Mice heterozygous for AKT1 have increased lifespan. TOR1, the S. cerevisiae orthologue of mTORC1, is a regulator of both carbon and nitrogen metabolism; TOR1 KO strains regulate response to nitrogen as well as carbon availability, indicating that it is a key nutritional transducer in yeast.
Sources: en.wikipedia.org
==== Plurality vs. unity of substantial form ==== Many medieval theologians and philosophers followed Aristotle in seeing a living being's soul as that being's form—specifically, its substantial form. However, they disagreed about whether X's soul is X's only substantial form. Some medieval thinkers argued that X's soul is X's only substantial form animating the entire body of X. In contrast, other medieval thinkers argued that a living being contains at least two substantial forms—(1) the shape and structure of its body, and (2) its soul, which makes its body alive.
=== Predators === The species Hydra oligactis is preyed upon by the flatworm Microstomum lineare. Some Coleps sp. have also been observed to attack Hydra polyps in groups, with them attacking Hydras' tentacles first before consuming the entire polyps. Some other common predators include carnivorous or omnivorous fishes such as guppies, bettas, and gouramis.
==== Spill control ==== A written policy needs to be in place in case of a spill of antineoplastic products. The policy should address the possibility of various sizes of spills as well as the procedure and personal protective equipment required for each size. A trained worker should handle a large spill and always dispose of all cleanup materials in the chemical waste container according to EPA regulations, not in a yellow chemotherapy waste container.
== Products == In terms of molecular structure, one distinguishes first between low-molecular-weight (LMW) and high-molecular-weight (HMW) products. The generally accepted threshold between LMW and HMW is a molecular weight of about 700 g/mol. LMW fine chemicals, also designated as small molecules, are produced by traditional chemical synthesis, by microorganisms (through fermentation or biotransformation), or by extraction from plants and animals. In the production of modern life science products, total synthesis from petrochemicals prevails. HMW products, or large molecules, are obtained mainly through biotechnology processes. Within LMWs, the N-heterocyclic compounds are the most important category; within HMWs, it is peptides and proteins.
compared perianal injectable bulking agents to sphincter training and biofeedback, and found the former to be superior. Both methods lead to an improvement of FI, but comparisons of St Mark's scores between the groups showed no difference between treatments. Anal manometry is sometimes used to investigate changes in the anal canal before and after the procedure. Usually mean anal resting pressure and mean anal squeeze pressure are the parameters used. Improvements in these measurements are often, but not always reported up to 3–12 months after the procedure. These improvements are not always maintained after 12 months. The length of the anal canal has also been reported to increase following the procedure. In one report, dextranomer did not increase anal resting or squeeze pressures. In the same study, dextranomer injections were found to be no different to biofeedback. There is limited research available on this topic, and these publications are mostly of poor quality. Apart from the available research, most of the claims of benefit of these procedures is anecdotal. One author criticized these procedures, stating that simply narrowing the anal canal was an instinctive and naïve solution which does not consider the complex pathopysiological mechanisms of FI. They suggested that these treatments are in theory suitable only for passive and minor forms of FI. Concerns have been raised about migration of the particles (in the case of Durasphere) away from the site of injection, or the total resorption of the material (in the case of hyaluronic acid and hydroxyl coaptite).
Sources: en.wikipedia.org
Sinosauropteryx was a small bipedal theropod, noted for its short arms, large first finger (thumbs), and long tail. The taxon includes some of the smallest known adult non-avian theropod specimens, with the holotype specimen measuring only 68 cm (27 in) in length, including the tail. However, this individual was relatively immature. The longest known specimen reaches up to 1.07 m (3.5 ft) in length, with an estimated weight of 0.55 kg (1.2 lb). A subsequent paper estimated its mass to be 0.99 kg (2.2 lb). Sinosauropteryx was anatomically similar to Compsognathus, differing from its European relatives in its proportions. The skull of Sinosauropteryx was 15% longer than its thigh bones, unlike in Compsognathus, where the skull and thigh bones are approximately equivalent in length. The arms of Sinosauropteryx (humerus and radius) were only 30% the length of its legs (thigh bone and shin), compared to 40% in Compsognathus. Additionally, Sinosauropteryx had several features unique among all other theropods. It had 64 vertebrae in its tail. This high number made its tail the longest relative to body length of any theropod. Its hands were long compared to its arms, about 84% to 91% of the length of the rest of the arm (humerus and radius), and half the length of the foot. The first and second digits were about the same length, with a large claw on the first digit. The first fingers were large, being both longer and thicker than either of the bones of the forearm.
the argyrophilic (silver staining) fibrous structures present in basement membranes histologically similar fibers present in developing connective tissue. The history of the reticulin silver stain is reviewed by Puchtler et al. (1978). The abstract of this paper says:
Paregoric, or camphorated tincture of opium, also known as tinctura opii camphorata, is a patent medicine known for its antidiarrheal, antitussive, and analgesic properties. According to Goodman and Gilman's 1965 edition, "Paregoric is a 4% opium tincture in which there is also benzoic acid, camphor, and anise oil. ... Paregoric by tradition is used especially for children." The term paregoric, which comes from Ancient Greek παρηγορικός parēgorikós "soothing", has also been used for boiled sweets which contained the substance, in particular the Army & Navy brand.
== Adverse effects == The US Food and Drug Administration label for the use of inotuzumab ozagamicin carries a boxed warning concerning the risk of liver toxicity, in particular hepatic veno-occlusive disease, which has been fatal in some people. The risk of this is higher in people who take the drug before having hematopoietic stem cell transplantation and more people die who have hematopoietic stem cell transplantation following treatment with this drug, than people who have hematopoietic stem cell transplantation, taking other chemotherapies. The risk gets higher as more rounds of treatment with inotuzumab ozogamicin are administered. The most common serious adverse reactions in people taking the drug in the clinical trial leading to approval include infections (23%), loss of neutrophils with fever (11%), hemorrhage (5%), stomach pain (3%), fever (3%), VOD (2%), and tiredness (2%). More than 20% of people had the following adverse reactions: loss of platelets (51%), loss of neutrophils (49%), infections (48%), anemia (36%), leukopenia (35%), tiredness (35%), hemorrhage (33%), fever (32%), nausea (31%), headache (28%), loss of neutrophils with fever (26%), elevated transaminases (26%), stomach pain (23%), and jaundice (21%). Between 10% and 20% of people also had loss of appetite, vomiting, diarrhea, mouth sores, constipation, chills, and injection site reactions. In studies in pregnant animals, the drug caused harm to the fetus at doses less than those used clinically, and so the drug has not been tested in pregnant women.
Sources: en.wikipedia.org
Cardarine is a common name for the investigational compound GW501516. It acts as a PPARδ agonist and is not approved for human use. It is prohibited in sport.
It activates PPARδ, a nuclear receptor that influences gene expression related to lipid and energy metabolism. Animal studies show changes in endurance and lipid levels. Human effects and risks are not well established.
No, cardarine is not a steroid. It belongs to a different chemical class, the PPARδ agonists. It is also not a selective androgen receptor modulator.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.